MedPath

Amckaus PTY LTD.

🇦🇺Australia
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:2

Trial Phases

1 Phases

Phase 1:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (100.0%)

QG101-23-0 Capsules SAD and MAD Study in Healthy Subjects

Phase 1
Completed
Conditions
Healthy Volunteers
Interventions
Drug: QG101-23-0 capsules
Drug: Placebo
First Posted Date
2022-12-14
Last Posted Date
2024-11-27
Lead Sponsor
Amckaus PTY LTD.
Target Recruit Count
78
Registration Number
NCT05650528
Locations
🇦🇺

CMAX Clinical Research Pty Ltd, Adelaide, Australia

Aom0319 SAD Study in Healthy Subjects

Phase 1
Completed
Conditions
Healthy Volunteers
Interventions
Drug: 0.9% Sodium Chloride Injection
First Posted Date
2022-09-27
Last Posted Date
2024-11-27
Lead Sponsor
Amckaus PTY LTD.
Target Recruit Count
38
Registration Number
NCT05555758
Locations
🇦🇺

Nucleus Network Pty Ltd, Melbourne, Australia

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.